Neurontin
Product Images NDC 0071-0401
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Neurontin (NDC 0071-0401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Neurontin 02)
Figure 1 (Neurontin 03)
Figure 2 (Neurontin 04)
Figure 3 (Neurontin 05)
Figure 4 (Neurontin 06)
Logo (Neurontin 07)
Logo (Neurontin 07a)
Principal Display Panel (100 mg Capsule Bottle Label)
Principal Display Panel (300 mg Capsule Bottle Label)
Principal Display Panel (300 mg Capsule Blister Pack)
Principal Display Panel (300 mg Capsule Blister Pack Carton)
Principal Display Panel (400 mg Capsule Bottle Label)
Principal Display Panel (400 mg Capsule Blister Pack)
Principal Display Panel (400 mg Capsule Blister Pack Carton)
Principal Display Panel (600 mg Tablet Bottle Label)
Principal Display Panel (800 mg Tablet Bottle Label)
Principal Display Panel (470 mL Bottle Label)
Principal Display Panel (470 mL Bottle Carton)
Principal Display Panel (470 mL Bottle Label)
Principal Display Panel (470 mL Bottle Carton)
Neurontin 21
Neurontin 22
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.